News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Redmile Group, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
SC 13D/A
| Redmile Group, LLC reports a 9.9% stake in IGM Biosciences, Inc. |
| 06/15/2023 |
SC 13D/A
| Redmile Group, LLC reports a 44.7% stake in Augmedix, Inc. |
| 05/04/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/21/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/19/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/02/2022 |
SC 13D/A
| Redmile Group, LLC reports a 40.8% stake in Augmedix, Inc. |
| 07/06/2022 |
SC 13D/A
| Redmile Group, LLC reports a 50.7% stake in MedAvail Holdings, Inc. |
| 06/15/2022 |
SC 13D/A
| Redmile Group, LLC reports a 17.1% stake in Science 37 Holdings, Inc. |
| 04/06/2022 |
SC 13D/A
| Redmile Group, LLC reports a 41.8% stake in MedAvail Holdings, Inc. |
| 04/05/2022 |
SC 13D/A
| Redmile Group, LLC reports a 12.9% stake in IGM Biosciences, Inc. |
| 01/14/2022 |
SC 13D/A
| Redmile Group, LLC reports a 34.3% stake in MedAvail Holdings, Inc. |
| 11/29/2021 |
SC 13D/A
| Redmile Group, LLC reports a 34.3% stake in MedAvail Holdings, Inc. |
| 11/01/2021 |
SC 13D/A
| Redmile Group, LLC reports a 41.1% stake in Augmedix, Inc. |
| 03/01/2021 |
SC 13D/A
| Redmile Group, LLC reports a 50.4% stake in Augmedix, Inc. |
| 01/12/2021 |
SC 13D/A
| Redmile Group, LLC reports a 14.1% stake in Fate Therapeutics, Inc. |
| 12/15/2020 |
SC 13D/A
| Redmile Group, LLC reports a 13.5% stake in IGM Biosciences, Inc. |
| 09/09/2020 |
SC 13D/A
| Redmile Group, LLC reports a 14.2% stake in IGM Biosciences, Inc. |
| 06/17/2020 |
SC 13D/A
| Redmile Group, LLC reports a 14.9% stake in Fate Therapeutics, Inc. |
| 10/24/2019 |
SC 13D/A
| Redmile Group, LLC reports a 0% stake in Alder BioPharmaceuticals, Inc. |
| 09/17/2019 |
SC 13D/A
| Redmile Group, LLC reports a 15.2% stake in Fate Therapeutics, Inc. |
| 09/17/2019 |
SC 13D/A
| Redmile Group, LLC reports a 10% stake in Alder BioPharmaceuticals, Inc. |
| 03/06/2019 |
SC 13D/A
| Redmile Group, LLC reports a 10% stake in Alder BioPharmaceuticals, Inc. |
| 09/27/2018 |
SC 13D/A
| Redmile Group, LLC reports a 16.2% stake in Fate Therapeutics, Inc. |
| 04/26/2018 |
SC 13D/A
| Redmile Group, LLC reports a 10% stake in Alder BioPharmaceuticals, Inc. |
|
|